Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sigknow Biomedical has commercialized two main products—EZYPRO®, an AI-powered continuous ECG patch monitor that enables up to 14 days of cardiac rhythm recording with professional analysis and reporting, and JustWipe®, the world’s first toilet-paper-like at-home fecal occult blood test kit. Clinical studies have shown EZYPRO® can increase arrhythmia diagnosis rates by three to five times compared to traditional Holter monitors (>60% detection rate), while JustWipe® provides rapid colorectal screening results within one minute. Both products are CE-marked and TFDA-approved in Taiwan.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sigknow Biomedical.